A look at the Orphan Drug Congress

Back In-Person! The Orphan Drug Congress, slated for this August 25 to 27 at the Gaylord National Resort & Convention Center, Oxon Hill, Maryland USA,...

A new drug for acromegaly: an insider’s look at the clinical trial

With the recent launch announcement of the phase 3 trial for Paltusotine - Crinetics new nonpeptide oral drug candidate for acromegaly - we asked...

A Conversation with Acromegaly Patient Advocates

We recently sat down with members of the acromegaly community to discuss their treatment journeys and the lessons they learned along the way, including...

Pregnancy and acromegaly

Acromegaly: what to do with medical treatment during pregnancy and the options available today.

Podcast: Living with Hypopituitarism

Rachael Clare was diagnosed with a pituitary macroadenoma at age 21.  Now at 28, in a frank and revealing chat, she shares her experiences...

Cushing’s disease and syndrome: The evolving story of hypercortisolism.

How is the emerging knowledge of hypercortisolism influencing how Cushing's disease and syndrome are understood and affecting the practice and those working on the...

The critical need for early diagnosis: a chat with Dr. Javier Salvador

At Pituitary World News, we are committed, some would say obsessed, with the need to reduce the time it takes to diagnose pituitary disease....

The Road to MYCAPSSA: A Conversation with Dr. Bill Ludlam

We recently had a chance to sit down with Chiasma Inc.’s Senior VP of Clinical Development & Medical Affairs, Dr. Bill Ludlam, to discuss...

A pituitary patient’s experience with COVID-19

A compelling, detailed account of a pituitary patient's experience with COVID-19 everyone should listen.  As the virus takes hold in what is undoubtedly the...

Telemedicine and COVID-19, insights from our survey

Not surprisingly, COVID-19 appears to have significantly impacted pituitary patients' access to healthcare.  Our brief survey elicited information from respondents on their experiences and...